Clinical Feasibility of the IMES Transradial Prosthesis

Sponsor
Össur Ehf (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT04936789
Collaborator
(none)
3
1
36

Study Details

Study Description

Brief Summary

This study will evaluate the feasibility of using implanted myoelectric sensors (IMES) to control a transradial prosthesis

Condition or Disease Intervention/Treatment Phase
  • Device: IMES
N/A

Detailed Description

The study assesses the feasibility of an implantable myoelectric prosthesis control system to control a transradial prosthesis. Implantable Myoelectric Sensors (IMES) will be implanted into the residual forearm muscles of three transradial amputee subjects. These devices wirelessly transmit electrical muscle signals to an electromechanical prosthetic wrist and hand.

Following a two-week recovery from implantation of up to 16 IMES into residual forearm muscles, subjects will begin a two week training phase. When they receive their custom-fit IMES Transradial Prosthesis (including electromechanical wrist and hand) subjects initiate approximately four months of home use. Subjects will be offered up to five post-study follow-up visits. The usability and functionality of the prosthetic system will be evaluated throughout the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Clinical Feasibility of the IMES Transradial Prosthesis
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single arm

Single arm. All subjects will receive the intervention. Comparator device will be subjects' own prosthesis at baseline.

Device: IMES
Surgical implantation of IMES

Outcome Measures

Primary Outcome Measures

  1. Grip Accuracy [The measure will be carried out 11 times during the study, at Baseline with the subject's own device for comparison, and at 10 study visits with the investigational device conducted over approximately 6 months.]

    Self-drafted assessment of accuracy in prosthesis movements. The purpose of this measure is to quantify subjects' ability to use the investigational device to control specific prosthetic movements. When performing the Accuracy Test, the subject attempts to execute a series of specified wrist and hand movements using the investigational device. An objective rater scores each movement on a 0-3 scale with 0 = no movement observed and and 3 = movement observed (with no unintended movements). A score is given for each movement and a combined score is derived from the complete set of movements. Administered as a repeated measure, the Grip Accuracy test assesses Change over time (training effect).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • (unilateral acquired transradial) amputation

  • residual limb size requirements to fit investigational device componentry

  • at least 6 residual muscle locations available for implantation

  • good compliance with health service (rehabilitation)

  • willing to undergo surgical implantation of IMES Sensor implants

  • experience with myoelectric upper limb prostheses

  • using own myoelectric device approximately 6-8h/day

  • able to provide informed consent and attend the study visits

Exclusion Criteria:
  • any condition which in the opinion of the investigator poses a risk to health

  • neurological disorder that may prohibit accurate control

  • major injury proximal to the level of amputation

  • neuromuscular disorder

  • nerve transection or palsy that may cause de-innervation of muscles planned for implantation

  • allergy to implanted materials

  • existing active implant

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Össur Ehf

Investigators

  • Principal Investigator: Aidan Roche, MD, NHS; University of Edinburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Össur Ehf
ClinicalTrials.gov Identifier:
NCT04936789
Other Study ID Numbers:
  • CIP2020072116
First Posted:
Jun 23, 2021
Last Update Posted:
Jun 23, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 23, 2021